New rapid test could spot COVID and flu in minutes

NCT ID NCT05787444

Completed Diagnosis Sponsor: LumiraDx UK Limited Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study checked how well a new rapid test (LumiraDx) detects COVID-19 and flu A/B from a simple nose swab. Over 1,000 people with symptoms took part at clinics. The test aims to give fast results at the point of care, helping doctors tell these illnesses apart quickly.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: LumiraDx SARS-CoV-2 & Flu A/B test (rapid diagnostic test)
What this could lead to: If successful, this test could provide quick, accurate results for COVID-19 and flu at clinics or pharmacies, helping doctors decide treatment faster.
What could go wrong: This is a completed validation study, not a treatment trial. The test may not be as accurate in real-world use or for asymptomatic people, and it only works within 6 days of symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASYMPTOMATIC COVID-19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19 influenza swine influenza

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASYMPTOMATIC COVID-19 INFLUENZA A INFLUENZA B SARS-COV-2

Contacts and locations

Locations

Cullman Clinical Trials

Cullman, Alabama, 35055, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.